BC
LABD icon

Boxer Capital’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Boxer Capital’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,000
Closed -$2.55M – 62
2024
Q1 		$2.55M Buy
+35,000
New +$2.92M 0.13% 52
2021
Q4 		– Sell
-15,000
Closed -$3.19M – 81
2021
Q3 		$3.19M Buy
+15,000
New +$3.19M 0.11% 80
2021
Q2 		– Sell
-125,000
Closed -$27.2M – 96
2021
Q1 		$27.2M Sell
125,000
-100,000
-44% -$19.4M 0.92% 33
2020
Q4 		$56.9M Buy
225,000
+200,000
+800% +$76.3M 1.83% 13
2020
Q3 		$14.9M Sell
25,000
-10,000
-29% -$6.45M 0.52% 44
2020
Q2 		$24.3M Buy
35,000
+28,750
+460% +$36.1M 1.07% 32
2020
Q1 		$17.6M Sell
6,250
-8,175
-57% -$23.3M 1.2% 26
2019
Q4 		$35.6M Buy
+14,425
New +$51.2M 2.02% 12

Other funds holding LABD

VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boxer Capital's LABD Position: Q2 2024 in Review

Boxer Capital sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2024, closing a stake of 35,000 shares — an estimated $2.55M sold.

Boxer Capital first reported a position in LABD in Q4 2019 and held it in 8 quarters. The position peaked at $56.9M in Q4 2020. 17 funds tracked by Wall St. Rank hold LABD as of Q2 2024.

  • Boxer Capital reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2024 after selling out during the quarter.
  • Boxer Capital sold 35,000 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2024, an estimated $2.55M.
  • Boxer Capital first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q4 2019 and held it in 8 quarters.
  • Boxer Capital's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $56.9M in Q4 2020.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2024.

Based on Boxer Capital's 13F filing for Q2 2024, filed 14 Aug 2024.